ABBV

2025Q2BMO

AbbVie Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-07-31 · Fiscal end 2025-06-30 · Features as of 2025-07-30

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.91
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.9%
IV front—
P/C full—
P/C front—
Features as of2025-07-30

Run-up

Close—
Ret 5d-0.7%
Ret 10d-0.7%
Ret 20d-0.4%
Ret 30d-0.8%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.97Beat
Estimated EPS2.91
Actual revenue
15.4B
Surprise %+2.1%
Beat / missBeat
Beat streak 44
Beat streak 84

Reaction

1-day stock reaction-4.1%
Implied vs actual

Implied 1.9%Actual 4.1%

Gap reaction+4.1%
Day result-0.2%
Next-day upNo
Realized / IV2.17×

Post tape

Post 5d+5.2%
Post 10d+8.3%
Post volume10.3M
Vol ×10d2.22×
Vol ×20d1.94×
Post range5.7%